2503-31-3

Basic information

• Product Name: Z-DL-ALA-GLY-OH
• Synonyms: Z-DL-ALA-GLY-OH;N-Cbz-DL-alanylglycine;CARBOBENZYLOXY-DL-ALANYLGLYCINE;Z-DL-Ala-Gly-OH99%
• CAS NO: 2503-31-3
• Molecular Formula: C₁₃H₁₆N₂O₅
• Molecular Weight: 280.28
• Mol File: 2503-31-3.mol
• Article Data: 18

Chemical Properties

• Appearance: /
• Storage Temp.: -15°C
• CAS DataBase Reference: Z-DL-ALA-GLY-OH(CAS DataBase Reference)
• NIST Chemistry Reference: Z-DL-ALA-GLY-OH(2503-31-3)
• EPA Substance Registry System: Z-DL-ALA-GLY-OH(2503-31-3)

Safety Data

• Hazardous Substances Data: 2503-31-3(Hazardous Substances Data)

Usage

General Description

Z-DL-ALA-GLY-OH is a chemical compound consisting of the amino acids D-alanine (Z-DL-ALA) and glycine (GLY) bonded together and ending with a hydroxyl group (OH). D-alanine is an important component in the formation of the bacterial cell wall and is also found in some antibiotics. Glycine is the simplest of all amino acids and is a crucial building block for proteins and other important compounds in the body. When combined, the Z-DL-ALA-GLY-OH compound may have potential applications in the fields of pharmaceuticals, biochemistry, and molecular biology. Its specific properties and potential uses would need to be further investigated and studied.

Upstream product

• 17126-93-1 Benzyloxycarbonyl-L-alaninphenylthiolester 
• 56-40-6 glycine 
• 5572-41-8 N-benzyloxycarbonyl-L-alanylaminoethanol 
• 6233-97-2 Z-Ala-OPcp 
• 820239-42-7 benzyl N-[(1S)-2-(1H-1,2,3-benzotriazol-1-yl)-1-methyl-2-oxoethyl]carbamate 
• 7364-42-3 N,O-bis(trimethylsilyl)glycine 
• 1142-20-7 N-Cbz-Ala 
• 4905-31-1 N-benzyloxycarbonylalanylglycine ethyl ester 
• 98347-08-1 Benzyloxycarbonyl-DL-alanin-selenophenylester 
• 2637-02-7 N-Benzyloxycarbonyl-DL-alanin-(1-selenonaphthyl)-ester 
• 3401-36-3 (N-benzyloxycarbonyl)-L-alanine N-hydroxysuccinimide ester 
• 76413-56-4 3-(N-benzyloxycarbonyl-L-alanyl)-1,3-thiazolidine-2-thione 
• 1168-87-2 benzyloxycarbonylalanine p-nitrophenyl ester 
• 56-41-7 L-alanin 

Downstream Products

• 111554-44-0 benzyloxycarbonylalanyl-glycine p-nitrophenyl ester 
• 49705-73-9 Z-Ala-Gly-Boc Hydrazid 
• 66962-63-8 C₅₂H₆₄N₆O₁₅ 
• 112120-49-7 Z-(Ala-Gly)2-OMe 
• 112120-50-0 Z-(Ala-Gly)3-OMe 
• 156916-70-0 t-butyl N^α-benzyloxycarbonyl-L-alanylglycyl-L-(β-t-butoxy)aspartyl-L-valinate 
• 151990-28-2 Z-L-Ala-Gly-L-Glu(OtBu)-Ser(tBu)-OtBu 
• 128228-46-6 [(S)-1-(5-Oxo-4,5-dihydro-oxazol-2-yl)-ethyl]-carbamic acid benzyl ester 
• 104542-58-7 2-methyl(N-carbobenzoxy-α-alanyl-glycyl)amido-5-bromobenzophenone 
• 36735-50-9 N-Benzoyloxycarbonyl-L-alanylglycinpentachlorophenylester 
• 176022-35-8 (S)-2-({(R)-1-[2-((S)-2-Benzyloxycarbonylamino-propionylamino)-acetylamino]-2-phenyl-ethyl}-methoxy-phosphinoyloxy)-3-phenyl-propionic acid 3-pyridin-4-yl-propyl ester 
• 1260405-54-6 Z-L-Ala-Gly-Bt 
• 1232149-54-0 Z-L-Ala-Gly-L-Cys-OH 
• 511303-01-8 Z-Ala-Gly-Ala-OMe 

Relevant articles and documents

CROSS-LINKED PYRROLOBENZODIAZEPINE DIMER (PBD) DERIVATIVE AND ITS CONJUGATES

A novel cross-linked cytotoxic agents, pyrrolobenzo-diazepine dimer (PBD) derivatives, and their conjugates to a cell-binding molecule, a method for preparation of the conjugates and the therapeutic use of the conjugates.

CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE

What provided is the conjugation of cytotoxic to a cell-binding molecule with a bis-linker(dual-linker) as shown in Formula (I). It provides bis-linkage methods of making a conjugate of a cytotoxic drug molecule to a cell-binding agent in a specific manner. It also relates to application of the conjugates for the treatment of a cancer, or an autoimmune disease, or an infectious disease.

Synthesis of selenoxo peptides and oligoselenoxo peptides employing LiAlHSeH

Synthesis of selenoxo peptides by the treatment of Nα- protected peptide esters with a combination of PCl5 and LiAlHSeH is delineated. The method is simple, high-yielding, and free from racemization. Thus obtained selenoxo peptides are used as units for N-terminal chain extension through Nα-deprotection/coupling to yield peptide-selenoxo peptide hybrids. Multiple selenation is demonstrated by conversion of two peptide bonds of tripeptides into selenoxo peptide bonds. Amino acid derived arylamides are also converted into aryl selenoamides. C6H 5-CSeNH-Val-OMe 8f is obtained as single crystal, and its structure was determined through X-ray diffraction study.